Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1988-10-20
1990-05-01
Lipovsky, Joseph A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
A61K 3156
Patent
active
049218433
ABSTRACT:
A method of contraception is disclosed which comprises a two-stage protocol. In the first stage, an estrogenic compound in a first composition is administered daily as the sole contraceptively active substance to a human female from about Day 2 to about Day 7 of her menstrual cycle, where Day 1 is the first day of menses. The second stage of the protocol occurs immediately thereafter during which at least one follow-up composition containing a progestin is administered daily to the same human female. The follow-up composition can contain a progestin as the sole contraceptively active ingredient, or can contain a combination of an estrogenic compound with a progestin in different weight ratios. A drug delivery system containing daily dosage units is also described.
REFERENCES:
patent: 4372951 (1983-02-01), Vorys
patent: 4544554 (1985-10-01), Pasquale
patent: 4616006 (1986-10-01), Pasquale
patent: 4621079 (1986-11-01), Lachnit-Fixson et al.
patent: 4628051 (1986-12-01), Pasquale
Goodman and Gilman, "The Pharmacological Basis of Therapeutics", 7th ed. (1985); pp. 1430-1436.
LandOfFree
Contraception system and method does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Contraception system and method, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Contraception system and method will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-829720